Pre-folding IκBα Alters Control of NF-κB Signaling

Journal of Molecular Biology

Volumn 380, Issue 1, 2008, Pages 67-82

  Truhlar, Stephanie M E ^a   Mathes, Erika ^a   Cervantes, Carla F ^a   Ghosh, Gourisankar ^a   Komives, Elizabeth A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

ankyrin repeat; coupled folding and binding; protein protein interactions; transcription factor regulation; ubiquitin independent proteasome degradation

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEASOME; UBIQUITIN; AMIDE; ANKYRIN; I KAPPA B; MUTANT PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; UREA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CONFORMATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME INHIBITION; EXPERIMENTAL STUDY; GENE MUTATION; GENETIC TRANSCRIPTION; IMMUNOPRECIPITATION; IN VITRO STUDY; ISOTHERMAL TITRATION CALORIMETRY; MOLECULAR DYNAMICS; MOUSE; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN FOLDING; REDUCTION KINETICS; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE; UPREGULATION; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; DRUG EFFECT; GENETICS; HUMAN; KINETICS; METABOLISM; MOLECULAR GENETICS; PROTEIN DENATURATION; PROTEIN PROCESSING; THERMODYNAMICS; TRANSACTIVATION; X RAY CRYSTALLOGRAPHY;

AMIDES; AMINO ACID SEQUENCE; ANIMALS; ANKYRIN REPEAT; CELL LINE; CRYSTALLOGRAPHY, X-RAY; HUMANS; I-KAPPA B PROTEINS; KINETICS; MICE; MOLECULAR SEQUENCE DATA; MUTANT PROTEINS; NF-KAPPA B; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; SIGNAL TRANSDUCTION; THERMODYNAMICS; TRANS-ACTIVATION (GENETICS); UREA;

EID: 44649146416     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.02.053     Document Type: Article

References (73)

1. Ghosh S., May M.J., and Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16 (1998) 225-260
2. Kumar A., Takada Y., Boriek A.M., and Aggarwal B.B. Nuclear factor-kappaB: its role in health and disease. J. Mol. Med. 82 (2004) 434-448
3. Verma I.M., Stevenson J.K., Schwarz E.M., Van Antwerp D., and Miyamoto S. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9 (1995) 2723-2735
4. Baeuerle P.A., and Baltimore D. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242 (1988) 540-546
5. Baldwin Jr. A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14 (1996) 649-683
6. Bergqvist S., Croy C.H., Kjaergaard M., Huxford T., Ghosh G., and Komives E.A. Thermodynamics reveal that helix four in the NLS of NF-kappaB p65 anchors IkappaBalpha, forming a very stable complex. J. Mol. Biol. 360 (2006) 421-434
7. Traenckner E.B., and Baeuerle P.A. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells. J. Cell Sci. 19 (1995) 79-84
8. Traenckner E.B., Pahl H.L., Henkel T., Schmidt K.N., Wilk S., and Baeuerle P.A. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli. EMBO J. 14 (1995) 2876-2883
9. Traenckner E.B., Wilk S., and Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 13 (1994) 5433-5441
10. Chen Z.J., Parent L., and Maniatis T. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84 (1996) 853-862
11. Brown K., Franzoso G., Baldi L., Carlson L., Mills L., Lin Y.C., et al. The signal response of IkappaB alpha is regulated by transferable N- and C-terminal domains. Mol. Cell. Biol. 17 (1997) 3021-3027
12. Pahl H.L. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18 (1999) 6853-6866
13. Scott M.L., Fujita T., Liou H.C., Nolan G.P., and Baltimore D. The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms. Genes Dev. 7 (1993) 1266-1276
14. Brown K., Park S., Kanno T., Franzoso G., and Siebenlist U. Mutual regulation of the transcriptional activator NF-kappa B and its inhibitor, I kappa B-alpha. Proc. Natl Acad. Sci. USA 90 (1993) 2532-2536
15. Sun S.C., Ganchi P.A., Ballard D.W., and Greene W.C. NF-kappa B controls expression of inhibitor I kappa B alpha: evidence for an inducible autoregulatory pathway. Science 259 (1993) 1912-1915
16. de Martin R., Vanhove B., Cheng Q., Hofer E., Csizmadia V., Winkler H., and Bach F.H. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B. EMBO J. 12 (1993) 2773-2779
17. Hoffmann A., Levchenko A., Scott M.L., and Baltimore D. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298 (2002) 1241-1245
18. Lee C.H., Jeon Y.T., Kim S.H., and Song Y.S. NF-kappaB as a potential molecular target for cancer therapy. Biofactors 29 (2007) 19-35
19. Krappmann D., Wulczyn F.G., and Scheidereit C. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo. EMBO J. 15 (1996) 6716-6726
20. Mathes, E., O'Dea, E. L, Hoffmann, A. & Ghosh, G. (2008). NF-kappaB dictates the degradation pathway of IkappaBalpha. EMBO J. In the press. doi:10.1038/emboj.2008.73.
21. O'Dea E.L., Barken D., Peralta R.Q., Tran K.T., Werner S.L., Kearns J.D., et al. A homeostatic model of IkappaB metabolism to control constitutive NF-kappaB activity. Mol. Syst. Biol. 3 (2007) 111
22. Rice N.R., and Ernst M.K. In vivo control of NF-kappa B activation by I kappa B alpha. EMBO J. 12 (1993) 4685-4695
23. O'Dea, E. L., Kearns, J. D. & Hoffmann, A. (2008). UV as an amplifier rather than inducer of NF-kappaB activity. Mol. Cell, in the press. doi:10.1016/j.molcel.2008.03.017.
24. Jacobs M.D., and Harrison S.C. Structure of an IkappaBalpha/NF-kappaB complex. Cell 95 (1998) 749-758
25. Huxford T., Huang D.B., Malek S., and Ghosh G. The crystal structure of the IkappaBalpha/NF-kappaB complex reveals mechanisms of NF-kappaB inactivation. Cell 95 (1998) 759-770
26. Mosavi L.K., Cammett T.J., Desrosiers D.C., and Peng Z.Y. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 13 (2004) 1435-1448
27. Li J., Mahajan A., and Tsai M.D. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45 (2006) 15168-15178
28. Kohl A., Binz H.K., Forrer P., Stumpp M.T., Pluckthun A., and Grutter M.G. Designed to be stable: crystal structure of a consensus ankyrin repeat protein. Proc. Natl Acad. Sci. USA 100 (2003) 1700-1705
29. Mosavi L.K., Minor Jr. D.L., and Peng Z.Y. Consensus-derived structural determinants of the ankyrin repeat motif. Proc. Natl Acad. Sci. U. S. A. 99 (2002) 16029-16034
30. Binz H.K., Amstutz P., Kohl A., Stumpp M.T., Briand C., Forrer P., et al. High-affinity binders selected from designed ankyrin repeat protein libraries. Nature Biotechnol. 22 (2004) 575-582
31. Mosavi L.K., and Peng Z.Y. Structure-based substitutions for increased solubility of a designed protein. Protein Eng. 16 (2003) 739-745
32. Ferreiro D.U., Cervantes C.F., Truhlar S.M., Cho S.S., Wolynes P.G., and Komives E.A. Stabilizing IkappaBalpha by "consensus" design. J. Mol. Biol. 365 (2007) 1201-1216
33. Truhlar S.M., Torpey J.W., and Komives E.A. Regions of IkappaBalpha that are critical for its inhibition of NF-kappaB. DNA interaction fold upon binding to NF-kappaB. Proc. Natl Acad. Sci. USA 103 (2006) 18951-18956
34. Croy C.H., Bergqvist S., Huxford T., Ghosh G., and Komives E.A. Biophysical characterization of the free IkappaBalpha ankyrin repeat domain in solution. Protein Sci. 13 (2004) 1767-1777
35. Love J.J., Li X., Chung J., Dyson H.J., and Wright P.E. The LEF-1 high-mobility group domain undergoes a disorder-to-order transition upon formation of a complex with cognate DNA. Biochemistry 43 (2004) 8725-8734
36. Kumar R., Betney R., Li J., Thompson E.B., and McEwan I.J. Induced alpha-helix structure in AF1 of the androgen receptor upon binding transcription factor TFIIF. Biochemistry 43 (2004) 3008-3013
37. Lee B.M., Xu J., Clarkson B.K., Martinez-Yamout M.A., Dyson H.J., Case D.A., et al. Induced fit and "lock and key" recognition of 5S RNA by zinc fingers of transcription factor IIIA. J. Mol. Biol. 357 (2006) 275-291
38. Radhakrishnan I., Perez-Alvarado G.C., Parker D., Dyson H.J., Montminy M.R., and Wright P.E. Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell 91 (1997) 741-752
39. Lacy E.R., Filippov I., Lewis W.S., Otieno S., Xiao L., Weiss S., et al. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nature Struct. Mol. Biol. 11 (2004) 358-364
40. Kriwacki R.W., Hengst L., Tennant L., Reed S.I., and Wright P.E. Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: conformational disorder mediates binding diversity. Proc. Natl Acad. Sci. USA 93 (1996) 11504-11509
41. Liu J., Perumal N.B., Oldfield C.J., Su E.W., Uversky V.N., and Dunker A.K. Intrinsic disorder in transcription factors. Biochemistry 45 (2006) 6873-6888
42. Sugase K., Dyson H.J., and Wright P.E. Mechanism of coupled folding and binding of an intrinsically disordered protein. Nature 447 (2007) 1021-1025
43. Demarest S.J., Martinez-Yamout M., Chung J., Chen H., Xu W., Dyson H.J., et al. Mutual synergistic folding in recruitment of CBP/p300 by p160 nuclear receptor coactivators. Nature 415 (2002) 549-553
44. Lacy E.R., Wang Y., Post J., Nourse A., Webb W., Mapelli M., et al. Molecular basis for the specificity of p27 toward cyclin-dependent kinases that regulate cell division. J. Mol. Biol. 349 (2005) 764-773
45. Camarero J.A., Shekhtman A., Campbell E.A., Chlenov M., Gruber T.M., Bryant D.A., et al. Autoregulation of a bacterial sigma factor explored by using segmental isotopic labeling and NMR. Proc. Natl Acad. Sci. USA 99 (2002) 8536-8541
46. Tripp K.W., and Barrick D. The tolerance of a modular protein to duplication and deletion of internal repeats. J. Mol. Biol. 344 (2004) 169-178
47. Ferreiro D.U., Cho S.S., Komives E.A., and Wolynes P.G. The energy landscape of modular repeat proteins: topology determines folding mechanism in the ankyrin family. J. Mol. Biol. 354 (2005) 679-692
48. Truhlar S.M.E., Croy C.H., Torpey J.W., Koeppe J.R., and Komives E.A. Solvent accessibility of protein surfaces by amide H/2H exchange MALDI-TOF mass spectrometry. J. Am. Soc. Mass Spectrom. 17 (2006) 1490-1497
49. Alvarez-Castelao B., and Castano J.G. Mechanism of direct degradation of IkappaBalpha by 20S proteasome. FEBS Lett. 579 (2005) 4797-4802
50. Liu C.W., Corboy M.J., DeMartino G.N., and Thomas P.J. Endoproteolytic activity of the proteasome. Science 299 (2003) 408-411
51. Tergaonkar V., Correa R.G., Ikawa M., and Verma I.M. Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity. Nature Cell Biol. 7 (2005) 921-923
52. Kearns J.D., Basak S., Werner S.L., Huang C.S., and Hoffmann A. IkappaBepsilon provides negative feedback to control NF-kappaB oscillations, signaling dynamics, and inflammatory gene expression. J. Cell Biol. 173 (2006) 659-664
53. Brown K., Gerstberger S., Carlson L., Franzoso G., and Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267 (1995) 1485-1488
54. Dyson H.J., and Wright P.E. Intrinsically unstructured proteins and their functions. Nature Rev. Mol. Cell Biol. 6 (2005) 197-208
55. Kloss E., Courtemanche N., and Barrick D. Repeat protein folding: New insights into origins of cooperativity, stability, and topology. Arch. Biochem. Biophys. 469 (2008) 83-99
56. Barrick D., Ferreiro D.U., and Komives E.A. Folding landscapes of ankyrin repeat proteins: experiments meet theory. Curr. Opin. Struct. Biol. 18 (2008) 27-34
57. Zweifel M.E., Leahy D.J., Hughson F.M., and Barrick D. Structure and stability of the ankyrin domain of the Drosophila Notch receptor. Protein Sci. 12 (2003) 2622-2632
58. Lowe A.R., and Itzhaki L.S. Rational redesign of the folding pathway of a modular protein. Proc. Natl Acad. Sci. USA 104 (2007) 2679-2684
59. Tang K.S., Guralnick B.J., Wang W.K., Fersht A.R., and Itzhaki L.S. Stability and folding of the tumour suppressor protein p16. J. Mol. Biol. 285 (1999) 1869-1886
60. Tripp K.W., and Barrick D. Enhancing the stability and folding rate of a repeat protein through the addition of consensus repeats. J. Mol. Biol. 365 (2007) 1187-1200
61. Cliff M.J., Williams M.A., Brooke-Smith J., Barford D., and Ladbury J.E. Molecular recognition via coupled folding and binding in a TPR domain. J. Mol. Biol. 346 (2005) 717-732
62. Penrose K.J., Garcia-Alai M., de Prat-Gay G., and McBride A.A. Casein kinase II phosphorylation-induced conformational switch triggers degradation of the papillomavirus E2 protein. J. Biol. Chem. 279 (2004) 22430-22439
63. Parsell D.A., and Sauer R.T. The structural stability of a protein is an important determinant of its proteolytic susceptibility in Escherichia coli. J. Biol. Chem. 264 (1989) 7590-7595
64. Asher G., Reuven N., and Shaul Y. 20S proteasomes and protein degradation "by default". BioEssays 28 (2006) 844-849
65. Malek S., Huxford T., and Ghosh G. Ikappa Balpha functions through direct contacts with the nuclear localization signals and the DNA binding sequences of NF-kappaB. J. Biol. Chem. 273 (1998) 25427-25435
66. Horn J.R., Kraybill B., Petro E.J., Coales S.J., Morrow J.A., Hamuro Y., and Kossiakoff A.A. The role of protein dynamics in increasing binding affinity for an engineered protein-protein interaction established by H/D exchange mass spectrometry. Biochemistry 45 (2006) 8488-8498
67. Baerga-Ortiz A., Bergqvist S., Mandell J.G., and Komives E.A. Two different proteins that compete for binding to thrombin have opposite kinetic and thermodynamic profiles. Protein Sci. 13 (2004) 166-176
68. Papworth C., Bauer J.C., Braman J., and Wright D.A. Site-directed mutagenesis in one day with (80% efficiency. Strategies 8 (1996) 3-4
69. Morgenstern J.P., and Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18 (1990) 3587-3596
70. Pace C.N. Determination and analysis of urea and guanidine hydrochloride denaturation curves. Methods Enzymol. 131 (1986) 266-280
71. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., and Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 6 (1995) 277-293
72. Johnson B.A., and Blevins R.A. NMR View - a computer-program for the visualization and analysis of NMR data. J. Biomol. NMR 4 (1994) 603-614
73. Wiseman T., Williston S., Brandts J.F., and Lin L.N. Rapid measurement of binding constants and heats of binding using a new titration calorimeter. Anal. Biochem. 179 (1989) 131-137